Skip to content

Psilocybin clinical trials: pipeline by phase and status

Every trial in this library's ClinicalTrials.gov slice that names Psilocybin: 299 registered studies, grouped by phase and by recruitment status. For the published research, see the Psilocybin research page.

The pipeline at a glance

By phase
PhaseTrials
Early phase 1 22
Phase 1 90
Phase 1/2 19
Phase 2 134
Phase 2/3 2
Phase 3 12
Not applicable 15
Unspecified 5
By status
StatusTrials
Recruiting or planned 137
Active, not recruiting 32
Completed 90
Stopped 22
Unknown or other 18

15,384 participants across the 299 trials that report enrollment. The earliest registered start is 2004, and 139 trials started in the last two years.

Most active sponsors

  • Johns Hopkins University 32 trials
  • Yale University 15 trials
  • NYU Langone Health 9 trials
  • University of Wisconsin, Madison 9 trials
  • Centre for Addiction and Mental Health 8 trials

Evidence by condition

All 299 trials

Most advanced phase first, and within each phase the most recent start date first.

Phase 3 12 trials

Phase 2/3 2 trials

Phase 2 134 trials

Phase 1/2 19 trials

Phase 1 90 trials

Early phase 1 22 trials

Not applicable 15 trials

Unspecified 5 trials

Data from ClinicalTrials.gov (opens in new tab), refreshed daily. Browse all clinical trials.